Welcome!

News Feed Item

Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

LONDON, Jan. 6, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

The cell surface markers market is undergoing impressive growth across the globe due to rapid automation of technologies and solutions, simplification of data management coupled with increasing preference for reduction of healthcare spending with a view to provide rapid and efficient decision making for therapies for specific diseases. On the other hand, high prevalence of chronic diseases such as cancer and autoimmune disorders has resulted in an elevated demand for cell surface markers analysis worldwide. Since their introduction, cell surface makers study has undergone tremendous technological development, and it is expected that soon end-users will be benefited from the increasing scope of applications of cell surface markers.

This report studies the cell surface markers market by the types of products commercially available for cell markers analysis. Each of the segments has been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million. The CAGR (%) of all segments has been provided for the forecast period of 2013 to 2019, considering 2012 as the base year.

In terms of geography, this market has been classified into North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. The respective market size for each region and their forecast till 2019 has also been presented in the report. In addition, a qualitative assessment of the market dynamics of the cell surface markers market has been provided, wherein the drivers, restraints, opportunities and market attractiveness has been studied.

The competitive landscape section of this report provides a bird's eye view of the major market players currently operating in this market and their respective products. Also, a pipeline snapshot of new entrants in this market along with their development stage products has been included. Some of the key market players profiled in this report include Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Grifols SA, Immucor, Inc. and Janssen Diagnostics, Inc.

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Trends and Future Outlook
3.2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
3.3 Drivers
3.3.1 Growing Automation in Laboratories
3.3.2 Discovery of New Markers will Need New Antibodies
3.3.3 Increased Use of In Vitro Diagnostics
3.3.4 Need for Lowering Healthcare Expenditure
3.4 Restraints
3.4.1 Reluctance for High Investment in Sophisticated Models
3.4.2 Complexity in the Use of Flow Cytometers
3.5 Opportunities
3.5.1 Growth in Expertise for Operation of Cell Marking Tools
3.5.2 Targeted Therapy and Personalized Medicine
3.6 Porter's Five Force Analysis for the Global Cell Surface Markers Market
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of New Entrants
3.6.4 Threat of Substitutes
3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis of Global Cell Surface Markers Market, by Instruments and Reagents, 2012

Chapter 4 Global Cell Surface Markers Market, by Instruments and Reagents
4.1 Overview – Current Market Scenario and Future Market Trends
4.1.1 Global Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
4.2 Flow Cytometry
4.2.1 Global Flow Cytometers Market Revenues, 2013 – 2019 (USD Million)
4.2.2 Global Flow Cytometers Market Volume, 2013 – 2019 (Number of Units Installed)
4.3 Hematology Analyzers
4.3.1 Global Hematology Analyzers Market Revenues, 2011 – 2019 (USD Million)
4.3.2 Global Hematology Analyzers Market Volume, 2013 – 2019 (Number of Units Installed)
4.4 Reagents and Kits
4.4.1 Global Reagent and Kits Market Revenues, 2011 – 2019 (USD Million)

Chapter 5 Global Cell Surface Markers Market, by Applications
5.1 Disease Diagnosis
5.1.1 Global Cell Surface Markers Market Revenues, by Disease Diagnosis and Identification, 2011 – 2019 (USD Million)
5.2 Research and Drug Discovery
5.2.1 Global Cell Surface Markers Market Revenues, by Research and Drug Discovery, 2011 – 2019 (USD Million)

Chapter 6 Global Cell Surface Markers Market, by Geography
6.1 Introduction
6.2 North America
6.2.1 North America Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
6.3 Europe
6.3.1 Europe Cell Surface Markers Market Revenues, Size and Forecast, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 Rest of the World (RoW) Cell Surface Markers Market Revenues, Size and Forecast, 2011 – 2019 (USD Million)

Chapter 7 Recommendations

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Company Overview
8.1.2 Strategic Overview
8.1.3 Financial Overview
8.1.4 Product Portfolio
8.1.5 Recent Developments
8.2 Beckman Coulter, Inc.
8.2.1 Company Overview
8.2.2 Strategic Overview
8.2.3 Financial Overview
8.2.4 Product Portfolio
8.2.5 Recent Developments
8.3 BD Biosciences
8.3.1 Company Overview
8.3.2 Strategic Overview
8.3.3 Financial Overview
8.3.4 Product Portfolio
8.3.5 Recent Development
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Company Overview
8.4.2 Strategic Overview
8.4.3 Financial Overview
8.4.4 Product Portfolio
8.4.5 Recent Development
8.5 Grifols SA
8.5.1 Company Overview
8.5.2 Strategic Overview
8.5.3 Financial Overview
8.5.4 Product Portfolio
8.5.5 Recent Development
8.6 Immucor, Inc.
8.6.1 Company Overview
8.6.2 Strategic Overview
8.6.3 Financial Overview
8.6.4 Product Portfolio
8.6.5 Recent Developments
8.7 Janssen Diagnostics, Inc.
8.7.1 Company Overview
8.7.2 Strategic Overview
8.7.3 Financial Overview
8.7.4 Product Portfolio
8.7.5 Recent development
8.8 Nihon Kohden Corporation
8.8.1 Company Overview
8.8.2 Strategic Overview
8.8.3 Financial Overview
8.8.4 Product Portfolio
8.8.5 Recent developments
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Strategic Overview
8.9.3 Financial Overview
8.9.4 Product Portfolio
8.9.5 Recent Developments
8.10 Siemens Healthcare
8.10.1 Company Overview
8.10.2 Strategic Overview
8.10.3 Financial Overview
8.10.4 Product Portfolio
8.10.5 Recent Developments
8.11 Sysmex Corporation
8.11.1 Company Overview
8.11.2 Strategic Overview
8.11.3 Financial Overview
8.11.4 Product Portfolio
8.11.5 Recent Development
8.12 Thermo Fischer Scientific, Inc.
8.12.1 Company Overview
8.12.2 Strategic Overview
8.12.3 Financial Overview
8.12.4 Product Portfolio
8.12.5 Recent Development

LIST OF FIGURES

FIG. 1 Cell Surface Markers: Market Segmentation
FIG. 2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2012 (USD Million)
FIG. 3 Global Cell Surface Markers Market Revenues, by Geography, 2012 (USD Million)
FIG. 4 Porter's Five Force Analysis: Global Cell Surface Markers Market
FIG. 5 Market Attractive Analysis: Global Cell Surface Markers Market, by Instruments and Reagents, 2012
FIG. 6 Global Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
FIG. 7 Global Flow Cytometers Market Revenues, 2011 - 2019 (USD Million)
FIG. 8 Global Flow Cytometers Market Volume, 2011 – 2019 (Number of Units Installed)
FIG. 9 Global Hematology Analyzers Market Revenues, 2011 - 2019 (USD Million)
FIG. 10 Global Hematology Analyzers Market Volume, 2011 – 2019 (Number of Units Installed)
FIG. 11 Global Reagents and Kits Market Revenues, 2011 - 2019 (USD Million)
FIG. 12 Global Cell Surface Markers Market Revenues, by Disease Diagnosis and Identification, 2011 - 2019 (USD Million)
FIG. 13 Global Cell Surface Markers Market Revenues, by Research and Drug Discovery, 2011 - 2019 (USD Million)
FIG. 14 North America Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 15 Europe Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 16 Asia-Pacific Cell Surface Markers Market Revenues, 2011 - 2019(USD Million)
FIG. 17 Rest of the World (RoW) Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 18 Annual Revenues of Abbott Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 19 Annual Revenues of Bio-Rad Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 20 Annual Revenues of Grifols SA, 2010 – 2012 (USD Million)
FIG. 21 Annual Revenues of Immucor, Inc., 2010 – 2012 (USD Million)
FIG. 22 Annual Revenues of Nihon Kohden Corp., 2010 – 2012 (USD Million)
FIG. 23 Annual Revenues of Hoffmann-La Roche Ltd., 2010 – 2012 (USD Million)
FIG. 24 Annual Revenues of Siemens Healthcare, 2010 – 2012 (USD Million)
+FIG. 25 Annual Revenues of Sysmex Corporation, 2010 – 2012 (USD Million)
FIG. 26 Annual Revenues of Thermo Fischer Scientific, Inc., 2010 – 2012 (USD Million)

LIST OF TABLES

TABLE 1 Market Snapshot: Global Cell Surface Markers Market
TABLE 2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 3 Global Cell Surface Markers Market Revenues, by Geography, Size and Forecast, 2013-2019 (USD Million)
TABLE 4 North America Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 5 Europe Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 6 Asia-Pacific Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 7 RoW Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)

Read the full report:
Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
http://www.reportbuyer.com/pharma_healthcare/diagnostics/cell_surface_markers_flow_cytometers_hematology_analyzers_reagents_kits_market_global_industry_analysis_size_share_growth_trends_forecast_2012_2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
UpGuard has become a member of the Center for Internet Security (CIS), and will continue to help businesses expand visibility into their cyber risk by providing hardening benchmarks to all customers. By incorporating these benchmarks, UpGuard's CSTAR solution builds on its lead in providing the most complete assessment of both internal and external cyber risk. CIS benchmarks are a widely accepted set of hardening guidelines that have been publicly available for years. Numerous solutions exist t...
"We're bringing out a new application monitoring system to the DevOps space. It manages large enterprise applications that are distributed throughout a node in many enterprises and we manage them as one collective," explained Kevin Barnes, President of eCube Systems, in this SYS-CON.tv interview at DevOps at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Choosing the right cloud for your workloads is a balancing act that can cost your organization time, money and aggravation - unless you get it right the first time. Economics, speed, performance, accessibility, administrative needs and security all play a vital role in dictating your approach to the cloud. Without knowing the right questions to ask, you could wind up paying for capacity you'll never need or underestimating the resources required to run your applications.
SYS-CON Events announced today that LeaseWeb USA, a cloud Infrastructure-as-a-Service (IaaS) provider, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. LeaseWeb is one of the world's largest hosting brands. The company helps customers define, develop and deploy IT infrastructure tailored to their exact business needs, by combining various kinds cloud solutions.
Adding public cloud resources to an existing application can be a daunting process. The tools that you currently use to manage the software and hardware outside the cloud aren’t always the best tools to efficiently grow into the cloud. All of the major configuration management tools have cloud orchestration plugins that can be leveraged, but there are also cloud-native tools that can dramatically improve the efficiency of managing your application lifecycle. In his session at 18th Cloud Expo, ...
The competitive landscape of the global cloud computing market in the healthcare industry is crowded due to the presence of a large number of players. The large number of participants has led to the fragmented nature of the market. Some of the major players operating in the global cloud computing market in the healthcare industry are Cisco Systems Inc., Carestream Health Inc., Carecloud Corp., AGFA Healthcare, IBM Corp., Cleardata Networks, Merge Healthcare Inc., Microsoft Corp., Intel Corp., an...
SYS-CON Events announced today the Kubernetes and Google Container Engine Workshop, being held November 3, 2016, in conjunction with @DevOpsSummit at 19th Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA. This workshop led by Sebastian Scheele introduces participants to Kubernetes and Google Container Engine (GKE). Through a combination of instructor-led presentations, demonstrations, and hands-on labs, students learn the key concepts and practices for deploying and maintainin...
StackIQ has announced the release of Stacki 3.2. Stacki is an easy-to-use Linux server provisioning tool. Stacki 3.2 delivers new capabilities that simplify the automation and integration of site-specific requirements. StackIQ is the commercial entity behind this open source bare metal provisioning tool. Since the release of Stacki in June of 2015, the Stacki core team has been focused on making the Community Edition meet the needs of members of the community, adding features and value, while ...
Using new techniques of information modeling, indexing, and processing, new cloud-based systems can support cloud-based workloads previously not possible for high-throughput insurance, banking, and case-based applications. In his session at 18th Cloud Expo, John Newton, CTO, Founder and Chairman of Alfresco, described how to scale cloud-based content management repositories to store, manage, and retrieve billions of documents and related information with fast and linear scalability. He addres...
Is your aging software platform suffering from technical debt while the market changes and demands new solutions at a faster clip? It’s a bold move, but you might consider walking away from your core platform and starting fresh. ReadyTalk did exactly that. In his General Session at 19th Cloud Expo, Michael Chambliss, Head of Engineering at ReadyTalk, will discuss why and how ReadyTalk diverted from healthy revenue and over a decade of audio conferencing product development to start an innovati...
Amazon has gradually rolled out parts of its IoT offerings in the last year, but these are just the tip of the iceberg. In addition to optimizing their back-end AWS offerings, Amazon is laying the ground work to be a major force in IoT – especially in the connected home and office. Amazon is extending its reach by building on its dominant Cloud IoT platform, its Dash Button strategy, recently announced Replenishment Services, the Echo/Alexa voice recognition control platform, the 6-7 strategic...
Ovum, a leading technology analyst firm, has published an in-depth report, Ovum Decision Matrix: Selecting a DevOps Release Management Solution, 2016–17. The report focuses on the automation aspects of DevOps, Release Management and compares solutions from the leading vendors.
Continuous testing helps bridge the gap between developing quickly and maintaining high quality products. But to implement continuous testing, CTOs must take a strategic approach to building a testing infrastructure and toolset that empowers their team to move fast. Download our guide to laying the groundwork for a scalable continuous testing strategy.
It’s 2016: buildings are smart, connected and the IoT is fundamentally altering how control and operating systems work and speak to each other. Platforms across the enterprise are networked via inexpensive sensors to collect massive amounts of data for analytics, information management, and insights that can be used to continuously improve operations. In his session at @ThingsExpo, Brian Chemel, Co-Founder and CTO of Digital Lumens, will explore: The benefits sensor-networked systems bring to ...
SYS-CON Events announced today that Venafi, the Immune System for the Internet™ and the leading provider of Next Generation Trust Protection, will exhibit at @DevOpsSummit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Venafi is the Immune System for the Internet™ that protects the foundation of all cybersecurity – cryptographic keys and digital certificates – so they can’t be misused by bad guys in attacks...